InsiderTradr

Sanjivani Paranteral Limited (SANJIVIN.BO)

BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic

₹166.70 (+12.10%) as of

Key statistics

Market cap
2.05B
P/E (TTM)
27.51
EPS (TTM)
6.06
Dividend yield
0.00%
52-week range
126.00 – 244.00
Beta
-0.01
Revenue (TTM)
746.13M
Profit margin
10.11%
Volume
20.90k

About Sanjivani Paranteral Limited

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, anti-fungal, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Mumbai, India
Employees
43

sanjivani.co.in

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks